Seoul, South Korea · Founded 2016 · Privately Held (backing)
Operator of a pharmaceutical company specializing in medical aesthetic products for anti-aging and skin rejuvenation. Koru Pharma is based in Seoul, South Korea and was founded in 2016. Its last reported valuation was $93.7 million in Apr 2026. It has raised $25.8 million.
Last reported valuation
$93.7M
Oct 2026
Priced at
—
Total raised
$25.8M
Last round
—
Cap table — not yet on record
Koru Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Koru Pharma with a free account
·Watch Koru Pharma: the Monday email on marks, rounds and moves
